 Google Inc.'s secretive Calico LLC life-sciences company unveiled a potential $1.5 billion research partnership with drug maker AbbVie Inc., marking the entrance of a potentially big player in developing treatments for age-related diseases.. Google has said little about Calico, in which it is the primary investor, since forming the company last year with former Genentech Inc. Chief Executive Arthur Levinson. On Wednesday, a Google spokesman declined to say how many employees Calico has or whether it had begun any other research...
  